197 related articles for article (PubMed ID: 32941853)
1. Loss of mu and delta opioid receptors on neurons expressing dopamine receptor D1 has no effect on reward sensitivity.
Harda Z; Spyrka J; Jastrzębska K; Szumiec Ł; Bryksa A; Klimczak M; Polaszek M; Gołda S; Zajdel J; Misiołek K; Błasiak A; Rodriguez Parkitna J
Neuropharmacology; 2020 Dec; 180():108307. PubMed ID: 32941853
[TBL] [Abstract][Full Text] [Related]
2. Analysis of dopamine receptor antagonism upon feeding elicited by mu and delta opioid agonists in the shell region of the nucleus accumbens.
Ragnauth A; Znamensky V; Moroz M; Bodnar RJ
Brain Res; 2000 Sep; 877(1):65-72. PubMed ID: 10980244
[TBL] [Abstract][Full Text] [Related]
3. Activity of mu- and delta-opioid agonists in vas deferens from mice deficient in MOR gene.
Maldonado R; Severini C; Matthes HW; Kieffer BL; Melchiorri P; Negri L
Br J Pharmacol; 2001 Apr; 132(7):1485-92. PubMed ID: 11264242
[TBL] [Abstract][Full Text] [Related]
4. Respiratory function in adult mice lacking the mu-opioid receptor: role of delta-receptors.
Morin-Surun MP; Boudinot E; Dubois C; Matthes HW; Kieffer BL; Denavit-Saubié M; Champagnat J; Foutz AS
Eur J Neurosci; 2001 May; 13(9):1703-10. PubMed ID: 11359522
[TBL] [Abstract][Full Text] [Related]
5. Differences among mouse strains in the regulation by mu, delta 1 and delta 2 opioid receptors of striatal adenylyl cyclases activated by dopamine D1 or adenosine A2a receptors.
Noble F; Cox BM
Brain Res; 1996 Apr; 716(1-2):107-17. PubMed ID: 8738226
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of dopamine D1-like receptor signaling by concomitant activation of δ- and μ-opioid receptors in mouse medial prefrontal cortex.
Olianas MC; Dedoni S; Onali P
Neurochem Int; 2012 Dec; 61(8):1404-16. PubMed ID: 23073238
[TBL] [Abstract][Full Text] [Related]
7. Effect of the highly selective and nonpeptide delta opioid receptor agonist TAN-67 on the morphine-induced place preference in mice.
Suzuki T; Tsuji M; Mori T; Misawa M; Endoh T; Nagase H
J Pharmacol Exp Ther; 1996 Oct; 279(1):177-85. PubMed ID: 8858991
[TBL] [Abstract][Full Text] [Related]
8. Differential modulation of mu- and delta-opioid receptor agonists by endogenous RGS4 protein in SH-SY5Y cells.
Wang Q; Liu-Chen LY; Traynor JR
J Biol Chem; 2009 Jul; 284(27):18357-67. PubMed ID: 19416973
[TBL] [Abstract][Full Text] [Related]
9. Implication of dopaminergic projection from the ventral tegmental area to the anterior cingulate cortex in μ-opioid-induced place preference.
Narita M; Matsushima Y; Niikura K; Narita M; Takagi S; Nakahara K; Kurahashi K; Abe M; Saeki M; Asato M; Imai S; Ikeda K; Kuzumaki N; Suzuki T
Addict Biol; 2010 Oct; 15(4):434-47. PubMed ID: 20731628
[TBL] [Abstract][Full Text] [Related]
10. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
11. Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1.
Vaughan CW; Bagley EE; Drew GM; Schuller A; Pintar JE; Hack SP; Christie MJ
Br J Pharmacol; 2003 May; 139(2):362-7. PubMed ID: 12770941
[TBL] [Abstract][Full Text] [Related]
12. Mu- and delta-opioid receptor agonists inhibit DARPP-32 phosphorylation in distinct populations of striatal projection neurons.
Lindskog M; Svenningsson P; Fredholm B; Greengard P; Fisone G
Eur J Neurosci; 1999 Jun; 11(6):2182-6. PubMed ID: 10336688
[TBL] [Abstract][Full Text] [Related]
13. mu/delta Cooperativity and opposing kappa-opioid effects in nucleus accumbens-mediated antinociception in the rat.
Schmidt BL; Tambeli CH; Levine JD; Gear RW
Eur J Neurosci; 2002 Mar; 15(5):861-8. PubMed ID: 11906528
[TBL] [Abstract][Full Text] [Related]
14. L-type and T-type calcium channel blockade potentiate the analgesic effects of morphine and selective mu opioid agonist, but not to selective delta and kappa agonist at the level of the spinal cord in mice.
Doğrul A; Yeşilyurt Ö; Işmer A; Güzeldemir EM
Pain; 2001 Jul; 93(1):61-68. PubMed ID: 11406339
[TBL] [Abstract][Full Text] [Related]
15. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
16. Comparison of G-protein activation in the brain by mu-, delta-, and kappa-opioid receptor agonists in mu-opioid receptor knockout mice.
Park Y; Ma T; Tanaka S; Jang C; Loh HH; Ko KH; Ho IK
Brain Res Bull; 2000 Jul; 52(4):297-302. PubMed ID: 10856828
[TBL] [Abstract][Full Text] [Related]
17. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
18. Shell/core differences in mu- and delta-opioid receptor modulation of dopamine efflux in nucleus accumbens.
Hipólito L; Sánchez-Catalán MJ; Zanolini I; Polache A; Granero L
Neuropharmacology; 2008 Aug; 55(2):183-9. PubMed ID: 18582908
[TBL] [Abstract][Full Text] [Related]
19. Mu opioid receptor-effector coupling and trafficking in dorsal root ganglia neurons.
Walwyn WM; Wei W; Xie CW; Chiu K; Kieffer BL; Evans CJ; Maidment NT
Neuroscience; 2006 Oct; 142(2):493-503. PubMed ID: 16887280
[TBL] [Abstract][Full Text] [Related]
20. Role of mu- and delta-opioid receptors in the nucleus accumbens in turning behaviour of rats.
Matsuzaki S; Ikeda H; Akiyama G; Sato M; Moribe S; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuropharmacology; 2004 Jun; 46(8):1089-96. PubMed ID: 15111015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
